The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 study of pembrolizumab in combination with azacitidine in subjects with metastatic colorectal cancer.
 
James J. Lee
Consulting or Advisory Role - Genentech
Research Funding - Merck
 
Weijing Sun
Honoraria - Genentech/Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer
Research Funding - Bayer; Merck (Inst)
 
Nathan Bahary
Consulting or Advisory Role - Bayer/Onyx; EMD Serono
Research Funding - Newlink Genetics
 
James Ohr
No Relationships to Disclose
 
John C. Rhee
No Relationships to Disclose
 
Ronald G. Stoller
No Relationships to Disclose
 
Stanley M. Marks
No Relationships to Disclose
 
Barry C. Lembersky
Speakers' Bureau - Genentech
 
H. Scott Beasley
No Relationships to Disclose
 
Summer Drummond
No Relationships to Disclose
 
Natalie Streeter
No Relationships to Disclose
 
Yongli Shuai
No Relationships to Disclose
 
Yan Lin
No Relationships to Disclose
 
James Herman
No Relationships to Disclose
 
Hassane M. Zarour
No Relationships to Disclose
 
Edward Chu
No Relationships to Disclose